Effects of denervation and hyperinnervation on dopamine and serotonin systems in the rat neostriatum: Implications for human Parkinson's disease

Neurochemistry International

Volumn 34, Issue 1, 1999, Pages 1-21

  Reader, T A ^a,b   Dewar, K M ^a,c  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b U de Neurologie du Comportement   (Canada)

^c CENTRE DE RECHERCHE FERNAND SEGUIN   (Canada)

Author keywords

6 hydroxydopamine; Dopamine receptors; Metabolism; Parkinson's disease; Serotonin receptors; aminobutyric acid

Indexed keywords

3 O METHYLDOPAMINE; 3,4 DIHYDROXYPHENYLACETIC ACID; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR; HOMOVANILLIC ACID; NEUROTOXIN; OXIDOPAMINE; SEROTONIN; SEROTONIN 2A RECEPTOR; SEROTONIN RECEPTOR;

CATECHOLAMINE NERVE CELL; DEAFFERENTATION; DENERVATION; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; HUMAN; INNERVATION; MONOAMINE METABOLISM; NEOSTRIATUM; NERVE PROJECTION; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; SEROTONINERGIC SYSTEM;

ANIMALIA;

EID: 0032965936     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(98)00048-5     Document Type: Review

References (242)

1. Abrous D.N., Rivet J.M., Le Moal M., Herman J.P. Brain Res. 526:1990;195-202.
2. Abrous D.N., Choulli K., Rouge-Pont F., Simon H., Le Moal M., Herman J.P. Neuroscience. 54:1993;499-511.
3. Agid Y., Javoy F., Glowinski J. Nature (New Biol.). 245:1973;150-151.
4. Altar C.A., Marien M.R. J. Neurosci. 7:1987;213-222.
5. Altar C.A., Marien M.R., Marshall J.F. J. Neurochem. 48:1987;390-399.
6. Andén N.-E., Carlsson A., Dahlström A., Fuxe K., Hillarp N.-A., Larsson K. Life Sci. 3:1964;523-530.
7. Andén N.-E., Fuxe K., Hamberger B., Hökfelt T. Actaphysiol. Scand. 67:1966;306-312.
8. Angulo J.A., Coirini H., Ledoux M., Schumacher M. Brain Res. 11:1991;161-166.
9. Arnt J. Life Sci. 37:1985;717-723.
10. Arnt J., Hytell J. Eur. J. Pharmacol. 102:1985;349-353.
11. Battaglia G., Norman A.B., Hess E.J., Creese I. Neurosci. Lett. 69:1986;290-295.
12. Becquet D., Faudon M., Héry F. BrainRes. 519:1990;82-88.
13. Ben-Shachar D., Youdim M.B. J. Neurochem. 57:1991;2133-2135.
14. Ben-Shachar D., Eshel G., Finberg J.P., Youdim M.B. J. Neurochem. 56:1991;1441-1444.
15. Berger T.W., Kaul S., Stricker E.M., Zigmond M.J. Brain Res. 336:1985;354-358.
16. Bernheimer H., Hornykiewicz O. Arch. Exp. Pathol. Pharmakol. 243:1962;295.
17. Bernheimer H., Birkmayer W., Hornykiewicz O. Klin.Wochenschr. 39:1961;1056-1059.
18. Bernheimer H., Birkmayer W., Hornykiewicz O., Jellinger K., Seitelberger F. J. Neurol. Sci. 20:1973;415-455.
19. Björklund A., Stenevi U., Schmidt R.H., Dunnett S.B., Gage F.H. Acta Physiol. Scand. 522:1983;9-18.
20. Blue M.E., Yagaloff K.A., Mamounas L.A., Hartig P.R., Molliver M.E. Brain Res. 453:1988;315-328.
21. Blunt S.B., Jenner P., Marsden C.D. Brain Res. 582:1992;299-311.
22. Bolam J.P., Smith A.D. Brain Res. 529:1990;57-78.
23. Bouyer J.J., Park D.H., Joh T.H., Pickel V.M. Brain Res. 302:1984;267-275.
24. Breese G.R., Traylor T.D. J. Pharmacol. Exp. Ther. 174:1970;413-420.
25. Breese G.R., Traylor T.D. Brit. J. Pharmacol. 42:1971;88-99.
26. Breese G.R., Baumeister A.A., McCown T.J., Emerick S.G., Frye G.D., Crotty K., Mueller R.A. J. Pharmacol. Exp. Ther. 231:1984;343-354.
27. Breese G.R., Baumeister A., Napier T.C., Frys G.D., Mueller R.A. J. Pharmacol. Exp. Ther. 235:1985;287-295.
28. Breese G.R., Napier T.C., Mueller R.A. J. Pharmacol. Exp. Ther. 234:1985;447-455.
29. Breese G.R., Duncan G.E., Napier T.C., Bondy S.C., Iorio L.C., Mueller R.A. J. Pharmacol. Exp. Ther. 240:1987;167-176.
30. Breese G.R., Criswell H.E., Johnson K.B., OCallaghan J.P., Duncan G.E., Jensen K.F., Simson P.E., Mueller R.A. Neurotoxicology. 15:1994;149-159.
31. Brené S., Lindefors N., Herrera-Marschitz M., Persson H. Brain Res. 21:1990;274-282.
32. Brené S., Herrera-Marschitz M., Persson H., Lindefors N. Brain Res. 83:1994;96-104.
33. Broaddus W.C., Bennett J.P. Brain Res. 52:1990;273-277.
34. Bruno J.P., Jackson D., Zigmond M.J., Stricker E.M. Behav. Neurosci. 101:1987;806-811.
35. Brus R., Kostrzewa R.M., Perry K.W., Fuller R.W. J. Pharmacol. Exp. Ther. 268:1994;231-237.
36. Bunzow J.R., Van Tol H.H.M., Grandy D.K., Albert P., Salon J., Christie M., Machida C.A., Neve K.A., Civelli O. Nature. 336:1988;783-787.
37. Buonamici M., Caccia C., Charpentierei M., Pegrassi L., Ross A.C., DiChiara G. Eur. J. Pharmacol. 126:1986;347-348.
38. Caboche J., Vernier P., Julien J.-F., Rogard M., Mallet J., Besson M.J. J. Neurochem. 56:1991;428-435.
39. Caboche J., Vernier P., Rogard M., Julien J.-F., Mallet J., Besson M.-J. J. Neurosci. 4:1992;438-447.
40. Cadet J.L., Brannock C. Neurochem. Int. 32:1998;117-131.
41. Cadet J.L., Katz M., Jackson-Lewis V., Fahn S. Brain Res. 476:1989;10-15.
42. Cadet J.L., Zhu S.M., Angulo J.A. Brain Res. 12:1992;59-67.
43. Cannon W.B. Amer. J. Med. Sci. 198:1939;737-750.
44. Carli M., Anand-Shrivastava M., Molina-Holgado E., Dewar K.M., Reader T.A. Neurochem. Int. 24:1994;13-22.
45. Castañeda E., Whishaw I.Q., Lermer L., Robinson T.E. Brain Res. 508:1990;30-39.
46. Chalmers D.T., Watson S.J. Brain. Res. 561:1991;51-60.
47. Chen J.F., Weiss B. Brain Res. 63:1991;95-104.
48. Chen J.F., Weiss B. Neurosci. Lett. 150:1993;215-218.
49. Chritin M., Savasta M., Mennicken F., Bal A., Abrous D.N., Le Moal M., Feuerstein C., Herman J.P. J. Neurosci. 4:1992;663-672.
50. Chritin M., Feuerstein C., Savasta M. Brain Res. 19:1993;318-322.
51. Chritin M., Blanchard V., Raisman-Vozari R., Feurstein C., Agid Y., Javoy-Agid F., Savasta M. J. Neurosci. 8:1996;2511-2520.
52. Cohen G. Adv. Neurol. 45:1987;119-125.
53. Cohen G., Heikkila R.E., Allis B., Cabbat D., Bembiec D., MacNamee D., Mytlineou C., Winston B. J.Pharmacol. Exp. Ther. 199:1976;336-352.
54. Commins D.L., Shaughnessy R.A., Axt K.J., Vosmer G., Seiden L.S. J. Neural Transm. 77:1989;197-210.
55. Compan V., Daszuta A., Salin P., Sebben M., Bockaert J., Dumuis A. J. Neurosci. 8:1996;2591-2598.
56. Creese I., Snyder S.H. Eur. J. Pharmacol. 56:1979;277-281.
57. Creese I., Burt D.R., Snyder S.H. Science. 197:1977;596-598.
58. Creese I., Sibley D.R., Xu S.X. Neurochem. Int. 20:1992;45-48.
59. Criswell H., Mueller R.A., Breese G.R. J. Neurosci. 9:1989;125-133.
60. Dahlström A., Fuxe K. Acta physiol. Scand. 62:1964;1-55.
61. Descarries L., Soghomonian J.-J., Garcia S., Doucet G., Bruno J.P. Brain Res. 569:1992;1-13.
62. Descarries L., Soucy J.-P., Lafaille F., Mrini A., Tanguay R. Synapse. 21:1995;131-139.
63. Dewar K.M., Soghomonian J.-J., Bruno J.P., Descarries L., Reader T.A. Brain Res. 536:1990;287-296.
64. Dewar KM, Paquet M., Reader T.A. Neurochem. Int. 30:1997;613-621.
65. Dostert P., Strolin Benedetti M., Della VedovaF., Alleivi C., La Croix R., Dordain G., Vernay D., Durif F. Adv. Neurol. 60:1993;218-223.
66. Doucet G., Descarries L., Garcia S. Neuroscience. 19:1986;427-445.
67. Duncan G.E., Breese G.R., Criswell H.E., Johnson K.B., Schambra U.B., Mueller R.A., Caron M.G., Fremeau R.T. J.Neurochem. 61:1993;1255-1262.
68. Ehringer H., Hornykiewicz O. Klin. Wochenschr. 38:1960;1236-1239.
69. El Mansari M., Radja F., Ferron A., Reader T.A., Molina-Holgado E., Descarries L. Eur. J. Pharmacol. 261:1994;171-178.
70. Ennis C., Kemp J.D., Cox B. J. Neurochem. 36:1981;1515-1520.
71. Ernoff L., Snodgrass S.R. Pharmacol. Biochem. Behav. 24:1986;1039-1045.
72. Farley, I.J., Hornykiewicz, O., 1976. Noradrenaline in subcortical brain regions of patients with Parkinsons disease and control subjects. In: Birkmayer, W., Hornykiewicz, O. (Eds.) Advances in Parkinsonism. Editions Roche, Basle, pp. 178-185.
73. Feltz P., De Champlain J. Brain Res. 43:1972;601-605.
74. Fernandes Xavier F.G., Doucet G., Geffard M., Descarries L. Neuroscience. 59:1994;77-87.
75. Fonnum F., Storm-Mathisen J., Divac I. Neuroscience. 6:1981;863-873.
76. Fornaguera J., Huston J.P., Carey R.J., Schwarting R.K. Psychopharmacology. 119:1995;145-154.
77. Fornaretto M.G., Caccia C., Caron M.G., Fariello R.G. Mol. Chem. Neuropathol. 19:1993;147-162.
78. Freund T.F., Powell J.F., Smith A.D. Neuroscience. 13:1984;1189-1215.
79. Garattini, S., Pujol, J.F., Samanin, R. (Eds.), 1978. Interactions Between Putative Neurotransmitters in the Brain. Raven Press, New York.
80. Gelbard H.A., Teicher M.H., Baldessarini R.J., Gallitano A., Marsh E.R., Zorc J., Faedda G. Brain Res. 56:1990;137-140.
81. Gerfen C.R., Young W.S. Brain Res. 460:1988;161-167.
82. Gerfen C.R., Engber T.M., Mahan L.C., Susel Z., Chase T.N., Monsma F.J. Jr., Sibley D.R. Science. 250:1990;1429-1432.
83. Gerfen C.R., McGinty J.F., Young W.S. J. Neurosci. 11:1991;1016-1031.
84. Girault J.A., Spampinato U., Savaki H.E., Glowinski J., Besson M.J. Neuroscience. 19:1986;1101-1108.
85. Girault J.A., Spampinato U., Glowinski J., Besson M.J. Neuroscience. 19:1986;1109-1117.
86. Giros B., Sokoloff P., Martres M.P., Riou J.F., Emorine L.J., Schwartz J.C. Nature. 342:1989;923-926.
87. Gong L., Kostrzewa R.M. Pharmacol. Biochem. Behav. 41:1992;621-623.
88. Gong L., Kostrzewa R.M., Fuller R.W., Perry K.W. J. Pharmacol. Exp. Ther. 261:1992;1000-1007.
89. Gong L., Kostrzewa R.M., Brus R., Fuller R.W., Perry K.W. Brain Res. 76:1993;59-65.
90. Gong L., Kostrzewa R.M., Perry K.W., Fuller R.W. Brain Res. 76:1993;233-238.
91. Gong L., Kostrzewa R.M., Li C. J. Neurochem. 63:1994;1282-1290.
92. Gozlan H., El Mestikawi S., Emerit M.B., Pichat L., Glowinski J., Hamon M. Nature. 305:1983;140-142.
93. Hall M.D., El Mestikawi S., Emerit M.B., Pichat L., Hamon M., Gozlan H. J. Neurochem. 44:1985;1685-1696.
94. Harsing L.G., Zigmond M.J. Brain Res. 738:1996;142-145.
95. Harsing L.G., Zigmond M.J. Neuroscience. 77:1997;419-429.
96. Hattori T., McGeer E.G., McGeer P.L. J. Comp. Neurol. 185:1978;347-354.
97. Hefti F., Melamed E., Wurtman R.J. Brain Res. 195:1980;123-137.
98. Herman J.P., Rouge-Pont F., Le Moal M., Abrous D.N. Neuroscience. 53:1993;1083-1095.
99. Herrera-Marschitz M., Ungerstedt U. Eur. J. Pharmacol. 98:1984;165-176.
100. 3H-noradrenaline and on noradrenaline-turnover in the rat heart. In: Malmfors, T., Thoenen, H. (Eds.). 6-Hydroxydopamine and Catecholamine Neurons. North-Holland, Amsterdam, pp. 279-289.
101. Hess E.J., Albers L.J., Le Hoang Creese I. J. Pharmacol. Exp. Ther. 238:1986;846-851.
102. Hökfelt T. Z. Zellforsch. 91:1968;1-74.
103. Hornykiewicz O. Adv. Neurol. 24:1979;275-281.
104. Hornykiewicz, O., 1982. Parkinsons disease. In: Crow, T.J. (Ed.), Disorders of Neurohumoral Transmission. Academic Press, London, pp.121-143.
105. Hu X.T., Wang R.Y. J. Neurosci. 8:1988;4340-4348.
106. Huang N., Kostrzewa R.M. Eur. J. Pharmacol. 253:1994;163-166.
107. Ingham C.A., Hood S.H., Arbuthnott G.W. Brain Res. 503:1989;334-338.
108. Ingham C.A., Hood S.H., Van MaldegemB., Weenik A., Arbuthnott G.W. Brain Res. 93:1993;17-27.
109. Ingham C.A., Hood S.H., Taggart P., Arbuthnott G.W. J. Neurosci. 18:1998;4732-4743.
110. Iwamoto E.T., Loh H.H., Way E.L. Eur. J. Pharmacol. 37:1976;339-356.
111. Iwata S., Nomoto M., Fukuda T. Jap. J. Pharmacol. 71:1996;255-258.
112. Jackson D., Abercrombie E.D. J. Neurochem. 58:1992;890-897.
113. Jackson D., Bruno J.P., Stachowiak M.K., Zigmond M.J. Brain Res. 457:1988;267-273.
114. Jonsson G., Sachs C. Eur. J. Pharmacol. 9:1970;141-155.
115. Jonsson G., Wiesel F.-A., Hallaman H. J. Neurobiol. 10:1979;337-353.
116. Joyce J.N. I. Effects of intranigral or intracerebroventricular. 113:1991;261-276.
117. Kemp J.M., Powell T.P.S. Philos. Trans. Roy. Soc. Lond. (Series B Biol. Sci.). 262:1971;413-427.
118. Kostrzewa R.M. Neurosci. Biobehav. Rev. 19:1995;1-17.
119. Kostrzewa R.M., Brus R. Pharmacol. Biochem. Behav. 39:1991;517-519.
120. Kostrzewa R.M., Gong L. Pharmacol. Biochem. Behav. 39:1991;677-682.
121. Kostrzewa R.M., Brus R., Perry K.W., Fuller R.W. Brain Res. 76:1993;87-93.
122. Kostrzewa R.M., Brus R., Kalbfleisch J.H., Perry K.W., Fuller R.W. Brain Res. 34:1994;161-167.
123. Kostrzewa R.M., Reader T.A., Descarries L. J. Neurochem. 70:1998;889-898.
124. Langer S.Z., Pimoule C., Reynolds G.P., Shoemaker H. Brit. J. Pharmacol. 87:1986;161.
125. Langston J.W., Ballard P., Tetrud J.W., Irwin I. Science. 219:1983;979-980.
126. Laprade N., Radja F., Reader T.A., Soghomonian J.-J. J. Neurosci. 16:1996;3727-3736.
127. Laverty R., Sharman D., Vogt M. Brit. J. Pharmacol. 24:1965;549-560.
128. Lawler C.P., Gilmore J.H., Watts V.J., Walker Q.D., Southerland S.B., Cook L.L., Mathis C.A., Mailman R.B. Synapse. 21:1995;299-311.
129. Le Moine C., Normand E., Bloch B. Proc. Natl. Acad. Sci. U.S.A. 88:1991;4205-4209.
130. Levi-Montalcini R., Booker B. Proc. Nat. Acad. Sci. U.S.A. 46:1960;384-391.
131. Lidov H.G.W., Molliver M.E. Brain Res. 8:1982;389-430.
132. Lindefors H., Brene S., Herrera-Marschitz M., Persson H. Brain Res. 77:1989;611-620.
133. Lindefors N., Brodin E., Tossman U., Segovia J., Ungerstedt U. BrainRes. 74:1989;527-534.
134. Lisovoski F., Haby C., Borrelli E., Schleef C., Revel M.O., Hindelang C., Zwiller J. Brain Res. 28:1992;697-701.
135. Ljungdahl ., Hökfelt T., Jonsson G., Sachs C. Experientia. 27:1971;297-299.
136. Lloyd K.G., Hornykiewicz O. Nature. 243:1973;521-523.
137. Lloyd K.G., Sheman L., Hornykiewicz O. Brain Res. 127:1977;269-278.
138. Loopuijt L.D., van der Kooy D. Brain Res. 348:1985;86-99.
139. Luthman J., Bolioli B., Tsutsumi T., Verhofstad A., Jonsson G. BrainRes. 19:1987;269-274.
140. Luthman J., Brodin E., Sundström E., Wiehager B. Int. J. Dev. Neurosci. 8:1990;549-560.
141. Luthman J., Lindqvist E., Young D., Cowburn R. Brain Res. 83:1990;85-95.
142. Luthman J., Fredriksson A., Plaznik A., Archer T. J. Psychopharmacol. 5:1991;418-425.
143. Malmfors T., Sachs C. Eur. J. Pharmacol. 3:1968;89-92.
144. Marcinkiewicz M., Verge D., Gozlan H., Hamon M. Brain Res. 291:1984;159-163.
145. Marshall J.F., Richardson J.S., Teitelbaum P. J. Comp. Physiol. Psychol. 87:1974;808-830.
146. Marshall J.F., Navarrete R., Joyce J.N. Brain Res. 493:1989;247-257.
147. Martres M.P., Sokoloff P., Giros B., Schwartz J.C. J. Neurochem. 58:1992;673-679.
148. Maruyama W., Dostert P., Matsubara K., Naoi M. Free Rad. Biol. Med. 19:1995;67-75.
149. McGeer P.L., McGeer E.G., Wada J.L., Jung E. Brain Res. 32:1971;425-431.
150. McGeer P.L., McGeer E.G., Scherer U., Singh K. Brain Res. 128:1977;369-373.
151. Mengod G., Pompeinano M., Martinez-Mir I., Palacios J.M. Brain Res. 524:1990;139-143.
152. Miquel M.C., Doucet E., Boni C., El Mestikawi S., Matthiessen L., Daval G., Verge D., Hamon M. Neurochem. Int. 19:1991;453-465.
153. Mishra R.K., Gardner E.L., Katzman R., Makman M.H. Proc. Natl. Acad. Sci. U.S.A. 71:1974;3883-3887.
154. Mishra R.K., Marshall A.M., Varmuza S.L. Brain Res. 200:1980;47-57.
155. Molina-Holgado E., Dewar K.M., Grondin L., van Gelder N.M., Reader T.A. J. Neurochem. 60:1993;936-945.
156. Molina-Holgado E., Dewar K.M., Grondin L., van Gelder N.M., Reader T.A. J. Neurosci. 35:1993;409-418.
157. Molina-Holgado E., Dewar K.M, Descarries L., Reader T.A. J. Pharmacol. Exp. Ther. 270:1994;713-721.
158. Molina-Holgado E., van Gelder N.M., Dewar K.M., Reader T.A. Neurochem. Int. 27:1995;443-451.
159. Molinoff P.B., Axelrod J. Annu. Rev. Biochem. 40:1971;465-500.
160. Morelli M., Mennini T., Di Chiara G. Neuroscience. 27:1988;865-870.
161. Mrini A., Soucy J.-P., Lafaille F., Lemoine P., Descarries L. BrainRes. 669:1995;303-308.
162. Mueller R.A., Thoenen H., Axelrod J. Science. 163:1969;468-469.
163. Murrin L.C., Gale K., Kuhar M.J. Eur. J. Pharmacol. 60:1979;229-235.
164. Murrin L.C., Zeng W. Brain Res. 480:1989;170-177.
165. Nagy J.I., Vincent S.R., Fibiger H.C. Life Sci. 22:1978;1777-1782.
166. Narang N., Wamsley J.K. J. Chem. Neuroanat. 9:1995;41-53.
167. Neal B.S., Joyce J.N. Synapse. 11:1992;35-46.
168. Nénonéné E.K., Radja F., Carli M., Grondin L., Reader T.A. J.Neurochem. 62:1994;1822-1834.
169. Neve K.A., Kozlowski M.R., Marshall J.F. Brain Res. 244:1982;33-44.
170. Neve K.A., Loeschen S., Marshall J.F. Brain Res. 329:1985;225-231.
171. Neve K.A., Neve R.L., Fidel S., Janowsky A., Higgins G.A. Proc.Natl. Acad. Sci. U.S.A. 88:1991;2802-2806.
172. Niva T., Takeda N., Yoshizumi H., Tatematsu A., Yoshida M., Dostert P., Naoi M., Nagatsu T. Biochem. Biophys. Res. Commun. 177:1991;603-609.
173. Numan S., Lundgren K.H., Wright D.E., Herman J.P., Seroogy K.B. BrainRes. 29:1995;391-396.
174. Onn S.P., Berger T.W., Stricker E.M., Zigmond M.J. Brain Res. 376:1986;8-19.
175. Pan H.S., Penney J.B., Young A.B. J. Neurochem. 45:1985;1396-1404.
176. Parenti M., Gentleman S., Olianas C., Neff N.H. Neurochem. Res. 7:1982;115-124.
177. Pazos A., Engel G., Palacios J.M. Brain Res. 343:1985;205-230.
178. Penit-Soria J., Durand C., Hervé D., Besson M.-J. Neuroscience. 77:1997;753-766.
179. Perumal A.S., Tordzro W.K., Katz M., Jackson-Lewis V., Cooper T.B., Fahn S., Cadet J.L. Brain Res. 504:1989;139-141.
180. Pickel V.M., Johnson E., Carson M., Chan J. Brain Res. 70:1992;75-86.
181. Porter C., Totara J., Stone C. J. Pharmacol. Exp. Ther. 140:1963;308-316.
182. Pou C., Nénonéné E.K., Reader T.A., Fargin A. Gen. Pharmacol. 29:1997;737-747.
183. Przedborski S., Levivier M., Jiang H., Ferriera M., Jackson Lewis V., Donaldson D., Togasaki D.M. Neuroscience. 67:1995;631-647.
184. Radja F., Daval G., Emerit M.B., Gallissot M.C., Hamon M., Verge D. Neuroscience. 31:1989;723-733.
185. Radja F., El Mansari M., Soghomonian J.-J., Dewar K.M., Ferron A., Reader T.A., Descarries L. Neuroscience. 57:1993;635-648.
186. Radja F., Descarries L., Dewar K.M., Reader T.A. Brain Res. 606:1993;273-285.
187. Reader, T.A., Jasper, H.H., 1984. Interactions between monoamines and other transmitters in cerebral cortex. In: Descarries, L., Reader, T.A., Jasper, H.H. (Eds.), Monoamine Innervation of Cerebral Cortex. Alan R. Liss, New York, pp. 195-225.
188. Reader T.A., Radja F., Dewar K.M., Descarries L. Ann. N.Y. Acad. Sci. 757:1995;293-310.
189. Reid M.S., OConnor W.T., Herrera-Marschitz M., Ungerstedt U. Brain Res. 519:1990;255-260.
190. Reisine T.D., Fields J.Z., Yamamura H.I., Bird E.D., Spokes E., Schreiner P.S., Enna S.J. Life Sci. 21:1977;335-344.
191. Riad M., El Mestikawi S., Verge D., Gozlan H., Hamon M. Neurochem. Int. 19:1991;413-423.
192. Rinne U.K., Lonnberg P., Koskinen V. J. Neural Transm. 51:1981;97-106.
193. Robertson H.A. Trends Neurosci. 15:1992;201-206.
194. Robinson T.E., Whishaw I.Q. Brain Res. 450:1988;209-224.
195. Samuel D., Kumar U., Nieoullon A. J. Neurochem. 51:1988;1704-1710.
196. Sandler M., Bonham Carter S., Hunter K.R., Stern G.M. Nature. 241:1975;439-443.
197. Saner A., Thoenen H. Molec. Pharmacol. 7:1971;147-154.
198. Savasta M., Dubois A., Feuerstein C., Mantier M., Scatton B. Neurosci. Lett. 74:1987;180-186.
199. Savasta M., Dubois A., Benavidès J., Scatton B. Neurosci. Lett. 85:1988;119-124.
200. Savasta M., Mennicken F., Chritin M., Abrous D.N., Feuerstein C., Le Moal M., Herman J.P. Neuroscience. 46:1992;729-738.
201. Segovia J., Tillakaratne N.J.K., Whelan K., Tobin A.J., Gale K. Brain Res. 529:1990;345-348.
202. Schultz W., Ungerstedt U. Neuropharmacology. 17:1978;180-186.
203. Sharp T., Zetterström T., Ungerstedt U. J. Neurochem. 47:1986;113-122.
204. Shibuya M. J. Neural Transm. 44:1979;287-295.
205. Smith Y., Bennett B.D., Bolam J.P., Parent A., Sadikot A.F. J. Comp. Neurol. 344:1994;1-19.
206. Snyder A.M., Zigmond M.J., Lund R.D. J. Comp. Neurol. 245:1986;274-281.
207. Snyder A.M., Keller W.R.Jr., Zigmond M.J. J. Pharmacol. Exp. Ther. 253:1990;867-876.
208. Soghomonian J.-J. Brain Res. 621:1993;249-259.
209. Soghomonian J.-J., Descarries L., Watkins K.C. Brain Res. 481:1989;67-86.
210. Soucy J.-P., Lafaille F., Lemoine P., Mrini A., Descarries L. J. Nucl. Med. 35:1994;1822-1830.
211. Stachowiak M.K., Bruno J.P., Snyder A.M., Stricker E.M., Zigmond M.J. Brain Res. 291:1984;164-167.
212. Stachowiak M.K., Bruno J.P., Snyder A.M., Strycker E.M., Zigmond M.J. J. Neurosci. 7:1987;1648-1654.
213. Starr M.S. Synapse. 19:1995;264-293.
214. Staunton D.A., Wolfe B.B., Groves P.M., Molinoff P.B. Brain Res. 211:1981;315-327.
215. Stone C.A., Stavorski J.M., Ludden C.T., Wenger H.C., Rosee C.A., Totara J.A., Porter C.C. J. Pharmacol. Exp. Ther. 142:1963;147-156.
216. Stromberg I., Adams C., Bygdeman M., Hoffer B., Boyson S., Humpel C. Brain Res. 38:1995;221-233.
217. Sunahara R.K., Niznik H.B., Weiner D.M., Storman T.M., Brann M.R., Kennedy J.L., Gelernter J.E., Rozmahelli R., Yang Y., Israel Y., Seeman P., O'Dowd B.F. Nature. 347:1990;80-83.
218. Takeuchi Y., Sawada T., Blunt S., Jenner P., Marsden C.D. Brain Res. 562:1991;301-305.
219. Tanaka Y., Niijima K., Mizumo Y., Yoshida M. Exp. Neurol. 91:1986;259-268.
220. Ternaux J.P., Héry S., Bourgouin S., Adrien J., Glowinski J., Hamon M. BrainRes. 121:1977;311-326.
221. Thoenen H., Tranzer J.P. Naunyn-Schmiedebergs Arch. Pharmakol. 261:1968;271-288.
222. Tossman U., Segovia J., Ungerstedt U. Acta Physiol. Scand. 127:1986;547-551.
223. Towle A.G., Criswell H.E., Maynard E.H., Lauder J.M., Joh T.H., Mueller R.A., Breese G.R. Pharmacol. Biochem. Behav. 34:1989;367-374.
224. Tranzer J.P., Thoenen H. Experientia. 24:1968;155-156.
225. Ungerstedt, U., 1971a. Histochemical studies on the effects of intracerebral and intraventricular injections of 6-hydroxydopamine on monoamine neurons in the rat brain. In: Malmfors, T., Thoenen, H. (Eds.). 6-Hydroxydopamine and Catecholamine Neurons, North-Holland, Amsterdam, pp. 101-127.
226. Ungerstedt, U., 1971b. Use of intracerebral injections of 6-hydroxydopamine as a tool for morphological and functional studies on central catecholamine neurons. In: Malmfors, T., Thoenen, H. (Eds.). 6-Hydroxydopamine and Catecholamine Neurons, North-Holland, Amsterdam, pp. 315-332.
227. Ungerstedt U., Arbuthnott G.W. Brain Res. 24:1970;485-493.
228. Heyden J.A.M., Venema K., Korf J. J. Neurochem. 34:1980;1338-1341.
229. Van Luijtelaar M.G.P.A., Wouterlood F.G., Tonnaer J.A.D.M., Steinbusch H.W.M. Synapse. 8:1991;162-168.
230. Vernier P., Julien J.-F., Rataboul P., Fourrier O., Feuerstein C., Mallet J. J. Neurochem. 51:1988;1375-1380.
231. Verge D., Daval G., Marcinkiewicz M., Patey A., El Mestikawy S., Gozlan H., Hamon M. J. Neurosci. 12:1986;3474-3482.
232. Voigt M.M., Laurie D.J, Seeburg P.H., Bach A. EMBO J. 10:1991;4017-4023.
233. Voorn P., Kalsbeek A., Jorritsma-Byham B., Groenewegen H.J. Neuroscience. 25:1988;857-887.
234. Westerink B.H.C. Neurochem. Int. 7:1985;221-227.
235. Wolf M.E., Zigmond M.J., Kapatos G. J. Neurochem. 53:1989;879-885.
236. Zhou F.C., Bledsoe S., Murphy J. Brain Res. 556:1991;108-116.
237. Zhou Q.-Y., Grandy D.K., Thambi L., Kushner J.A., Van Tol H.H.M., Cone R., Prignow D., Salon J., Bunzow J.R., Civelli O. Nature. 347:1990;76-80.
238. Zigmond M.J., Stricker E.M. Science. 177:1972;1211-1214.
239. Zigmond M.J., Stricker E.M. Science. 182:1973;717-720.
240. Zigmond, M.J., Stricker, E.M., 1989. Animals models of parkinsonism using selective neurotoxins: Clinical and basic implications. In: Bradley, R.J. (Ed.) International Review of Neurobiology. Vol. 31, Academic Press, New York, pp.1-79.
241. Zigmond M.J., Acheson A.L., Stachowiak M.K., Stricker E.M. Arch. Neurol. 41:1984;856-861.
242. Zigmond M.J., Abercrombie E.D., Berger T.W., Grace A.A., Stricker E.M. Trends Neurosci. 13:1990;290-296.